[The death ligands CD95L and Apo2L/TRAIL are promising investigational agents for the treatment of malignant glioma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine.
Gene-disease associations inferred from text-mining the literature.
DisGeNET evidence - LITERATURE